Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by in Pharma R&D

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »

Making the Promise of Immunotherapeutics into Reality

Posted on August 2nd, 2017 by in Chemistry

This is an exciting and hopeful time for cancer research, as new therapies and approaches are being explored that offer an alternative to standard chemotherapy, which can be effective but often carries a number of harsh side effects. Continue reading “Making the Promise of Immunotherapeutics into Reality” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

Start-Up Spotlight: StemCiTerra, LLC

Posted on February 17th, 2017 by in Pharma R&D

StemCiTerra, LLC is a small American start-up with a mission to make cancer treatments more effective. The company’s President & CSO, Lyubov Ostrovska, Ph.D., chats about their research. Continue reading “Start-Up Spotlight: StemCiTerra, LLC” »

  1. 1
  2. 2